Tag Archives: technology

Tuesday, October 22nd 2019 at 1:00pm UTC SCOTTSDALE, Ariz.–(BUSINESS WIRE)– Systems Oncology, LLC (“SO”) and The Pritzker Organization, LLC (“TPO”) announced today that Pritzker Family Business Interests advised by TPO have invested in the first closing of SO’s Series B round. The funding will be used to invest in both …

Monday, October 21st 2019 at 1:00pm UTC AI-powered RAPID ICH Advanced Imaging Quickly Notifies Clinicians of Possible Intracranial Hemorrhage SAN FRANCISCO–(BUSINESS WIRE)– iSchemaView, the worldwide leader in advanced imaging for stroke, today launched the newest addition to the RAPID platform, RAPID ICH1 at the 2019 Congress of Neurological Surgeons (CNS) …

Monday, October 21st 2019 at 2:49pm UTC BOSTON–(BUSINESS WIRE)– Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced that Corey McCann M.D., Ph.D., President and CEO, will participate in two panel discussions on addiction and digital therapeutics at the 2019 HLTH Conference being held October 27- 30 …

Tuesday, October 22nd 2019 at 12:00pm UTC ABI-LAB startups can now use LabTwin’s voice and AI-powered digital lab assistant as part of a smart lab to streamline data management and make research more efficient BERLIN–(BUSINESS WIRE)– LabTwin ??GmbH, the world’s first voice and AI-powered digital lab assistant, today announced a …

Monday, October 21st 2019 at 1:35pm UTC – Diaceutics finds the average precision medicine drug is launched 4.5 years before the accompanying diagnostic test is available to all patients, therefore denying patients access to the newest therapies – Pharma’s precision testing pre-launch investment is being monopolized by a small number …

Friday, October 18th 2019 at 2:47am UTC PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)– Xcovery Holdings, Inc., an oncology-focused biopharmaceutical company, today announced that ensartinib, the company’s lead drug candidate, demonstrated efficacy and safety in patients with crizotinib-refractory, anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC), including those with brain …

Friday, October 18th 2019 at 12:00pm UTC This market will accelerate at a CAGR of more than 6% between 2019 and 2023 LONDON–(BUSINESS WIRE)– The report, global ventricular drainage devices market, has been added to Technavio’s catalog. It provides a comprehensive analysis of the market, including its global and regional …

Wednesday, October 16th 2019 at 5:58pm UTC NEWBURY PARK, Calif.–(BUSINESS WIRE)– Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will showcase its Orthopaedic Advantage™ suite of Ortho-specific solutions at the American Shoulder and Elbow Surgeons annual meeting …

Wednesday, October 16th 2019 at 7:00am UTC Latest round of funding, led by Atomico, will be used to build a clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism Healx’s Rare Treatment Accelerator programme is a new initiative launched in close partnership …

Wednesday, October 16th 2019 at 5:02am UTC Actuellement en cours d’études de phase 1, l’agoniste du FXR, TERN-101, démontre le potentiel pour la distribution tissulaire enrichie dans le foie FOSTER CITY, Californie et SHANGHAI–(BUSINESS WIRE)– Terns Pharmaceuticals, Inc., une entreprise biopharmaceutique internationale axée sur la découverte et le développement de …